JP Morgan Maintains Overweight on Replimune Group, Raises Price Target to $50
Portfolio Pulse from richadhand@benzinga.com
JP Morgan analyst Anupam Rama maintains an Overweight rating on Replimune Group (NASDAQ:REPL) and raises the price target from $38 to $50.
June 15, 2023 | 12:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JP Morgan analyst Anupam Rama maintains an Overweight rating on Replimune Group and raises the price target from $38 to $50.
The news of JP Morgan maintaining an Overweight rating on Replimune Group and raising the price target from $38 to $50 is positive for the stock. This indicates that the analyst has a bullish outlook on the company's performance and expects the stock price to rise in the short term. As a result, the stock price is likely to go up in response to this news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100